Vascular endothelial growth factor-A (VEGF-A) in vitreous fluid of patients with proliferative diabetic retinopathy.
VEGA-A concentration was measured in undiluted vitreous fluid samples were taken at the start of vitrectomy procedure from 9 new cases of proliferative diabetic retinopathy and 8 non-diabetic patients. A positive correlation was found between VEGF-A levels and blood sugar and HgbA1c levels of patients with proliferative diabetic retinopathy.
Kant
Shri
S
Department of Ophthalmology, Institute of Medical Sciences Banaras Hindu University, Varanasi-221005, India. Kantshri@sify.com
Seth
Gaurav
G
Anthony
Kamson
K
D015415:Biomarkers / Q000378:metabolism; D001786:Blood Glucose / Q000032:analysis; D003930:Diabetic Retinopathy / Q000175:diagnosis / Q000378:metabolism* / Q000601:surgery; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005500:Follow-Up Studies; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism*; D014821:Vitrectomy; D018630:Vitreoretinopathy, Proliferative / Q000175:diagnosis / Q000378:metabolism* / Q000601:surgery; D014822:Vitreous Body / Q000378:metabolism* / Q000601:surgery
D015415:Biomarkers; D001786:Blood Glucose; D006442:Glycated Hemoglobin; D042461:Vascular Endothelial Growth Factor A; C467484:VEGFA protein, human; C517652:hemoglobin A1c protein, human